Obesity, Diabetes and the Metabolic Syndrome

Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Kevin C. Maki, PhD, FNLA, CLS Host Dr. Alan S. Brown is joined by Kevin C. Maki, PhD, FNLA, Chief Science Officer of Biofortis Clinical Research. Dr. Maki will review obesity, metabolic syndrome and type 2 diabetes mellitus as they are all insulin resistant states and are often characterized by atherogenic dyslipidemia or the "lipid triad" of elevated triglycerides, low HDL cholesterol and a predominance of small, dense LDL particles.